Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (Q28244389)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
scientific article (publication date: September 2007)
Language Label Description Also known as
English
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
scientific article (publication date: September 2007)

    Statements

    title
    Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    17767166
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    4 January 2020
    author name string
    cites work

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q28244389&oldid=2175151578"